4//SEC Filing
Plassche Douglas 4
Accession 0001641172-25-018199
CIK 0001053369other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:15 PM ET
Size
6.9 KB
Accession
0001641172-25-018199
Insider Transaction Report
Form 4
Plassche Douglas
EVP Operations
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2025-07-03$0.03/sh+2,500,000$75,000→ 2,500,000 total - Exercise/Conversion
Stock Options (right to buy)
2025-07-03−2,500,000→ 5,000,000 totalExercise: $0.03From: 2025-01-03Exp: 2033-01-03→ Common Stock (2,500,000 underlying)
Footnotes (1)
- [F1]All of the stock options were fully vested and exercisable as of the transaction date.
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeother
Related Parties
1- filerCIK 0001600946
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:15 PM ET
- Size
- 6.9 KB